| Bioactivity | SGK1-IN-5 (Compound 1) is an inhibitor for serum and glucocorticoid regulated kinase SGK 1 with an IC50 of 3 nM. SGK1-IN-5 inhibits SGK-1 dependent phosphorylation of GSK3β in U2OS cells with an IC50 of 1.4 μM. SGK1-IN-5 can be used in research about osteoarthritis or rheumatism[1]. |
| CAS | 1426214-51-8 |
| Formula | C17H12Cl2N6O2S |
| Molar Mass | 435.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nazare M, et al., N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS. US20130072493. |
SGK1-IN-5
CAS: 1426214-51-8 F: C17H12Cl2N6O2S W: 435.29
SGK1-IN-5 (Compound 1) is an inhibitor for serum and glucocorticoid regulated kinase SGK 1 with an IC50 of 3 nM. SGK1-IN
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.